Safety of Zafirlukast: Results of a Postmarketing Surveillance Study on 7976 Patients in England

By Twaites Beverley R.   Wilton Lynda V.   Shakir Saad A.W.  

Drug Safety, Vol. 30, Iss. 5, 2007-01 ,pp. : 419-429

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Nifedipine GITS in Asians with Hypertension: Results of a Post-Marketing Surveillance Study in China

By Runlin Gao  

Clinical Drug Investigation, Vol. 27, Iss. 8, 2007-01 ,pp. : 565-572

Adis International

Access to resources Recommend Favorite

Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging: Results of a Post-Marketing Surveillance Study in Japan

By Ishiguchi Tsuneo  

Drugs in R&D, Vol. 10, Iss. 3, 2010-09 ,pp. : 133-145

Adis International

Access to resources Recommend Favorite

The Real-life Safety and Efficacy of Vardenafil: an International Post-marketing Surveillance Study – Results from 29 358 German Patients

By van Ahlen H   Zumbé J   Stauch K   Landen H  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 337-348

Field House Publishing

Access to resources Recommend Favorite

Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use: A 12-Week, Open-Label, Post-Marketing Surveillance Study

By Michel Martin C.  

Drug Safety, Vol. 31, Iss. 6, 2008-01 ,pp. : 505-514

Adis International

Access to resources Recommend Favorite